Nervous System Disease Biomarker Detection Service

The complexity of the nervous system and the diversity of nervous system diseases make the diagnosis and treatment of these diseases very difficult. The use of biomarkers may promote early diagnosis and treatment monitoring of neurological diseases. Creative BioMart Biomarker has rich experience in the field of biomarkers and has a mature technology platform for the detection of single biomarkers. We provide detection services for various biomarkers related to nervous system diseases, and are committed to helping customers obtain high-quality biomarker detection services and shorten the research cycle.

Introduction

The nervous system is a very complicated organ system of the human body, which is responsible for regulating and controlling the physiological functions in the body. The nervous system of the human body is mainly composed of the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS includes the brain and spinal cord, and the PNS consists of nerves. Nervous system diseases refer to a series of diseases that affect CNS and PNS, including more than 600 diseases such as degenerative diseases and developmental diseases. Since the main function of the nervous system is signal transmission and regulation of physiological functions, diseases of the nervous system may cause patients to temporarily lose part of their physiological functions, resulting in the loss of sensation, memory, cognition or exercise ability, which seriously affects the health and life of patients. The nervous system is mostly protected by physical and chemical barriers. For example, the CNS is protected by the skull, vertebrae, and blood-brain barrier. The causes of nervous system diseases are complex and the clinical manifestations are different. Therefore, the diagnosis of the nervous system is difficult when the disease occurs. Early diagnosis of the disease helps to improve the treatment effect. The research of biomarkers in the field of clinical diagnosis is developing rapidly, and may be used as an auxiliary method to help early diagnosis of nervous system diseases. For example, cerebrospinal fluid (CSF) is an important energy source for biomarkers related to nervous system diseases. Obtained biomarkers from CSF can help monitor the development of diseases, predict and track the response of patients to treatment. In addition, biomarkers may help to achieve personalized medical treatment of diseases. Therefore, biomarkers have broad development prospects in the diagnosis and treatment of nervous system diseases such as Alzheimer’s disease and Parkinson’s disease.

Nervous System Disease Biomarker Detection Service

Our Advantages

  • Guarantee high accuracy and sensitivity for single biomarker detection
  • Ensure high repeatability of single biomarker detection
  • Short turn-around time of detection service
  • Competitive price in the market of detection services
  • Provide multiple detection methods
  • Accept a wide range of sample types

Our Single Biomarker Detection Services Related to Nervous System Disease (including but not limited to the following):

Workflow of Single Biomarker Detection at Creative BioMart Biomarker

Creative BioMart Biomarker strictly controls each specific experimental step in the single biomarker detection procedure to ensure accurately quantify the level of each biomarker.

Nervous System Disease Biomarker Detection Service

At Creative BioMart Biomarker, we offer nervous system disease biomarker detection services that include several technical platforms, you can communicate with our experts according to your research needs, and we will determine the final detection technological scheme based on the communication results. Please feel free to contact us, Creative BioMart Biomarker is here to offer you professional and thoughtful service.

References:

  1. Farah, R.; et al. Salivary biomarkers for the diagnosis and monitoring of neurological diseases. Biomedical Journal. 2018, 41(2): 63–87.
  2. Garden, G. A.; Campbell, B. M. Glial biomarkers in human central nervous system disease. Glia. 2016, 64(10): 1755–1771.

Related Services:

Menu

Contact Us

Subscribe

Enter your email here to subscribe